Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy
<p>Abstract</p> <p>Background</p> <p>To investigate the significance of monitoring the levels of the serum squamous cell carcinoma antigen (SCC-Ag) for the detection of recurrent disease in patients with cervical cancer treated by concurrent chemoradiotherapy.</p>...
Main Authors: | Yoon Sang, Shin Kyung, Kim Joo-Young, Seo Sang, Park Sang-Yoon, Moon Sung, Cho Kwan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-09-01
|
Series: | Radiation Oncology |
Online Access: | http://www.ro-journal.com/content/5/1/78 |
Similar Items
-
Usefulness of Short-Term Imaging and Squamous Cell Carcinoma Antigen to Early Predict Response to Concurrent Chemoradiotherapy in Patients With Cervical Cancer
by: Ji Geun Yoo MD, et al.
Published: (2022-01-01) -
Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.
by: Gun Oh Chong, et al.
Published: (2015-01-01) -
Average log change rate of pretreatment squamous cell carcinoma antigen after concurrent chemoradiotherapy in stage IIIC1 cervical squamous cell carcinoma
by: Oyeon Cho, et al.
Published: (2024-04-01) -
Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma
by: Oyeon Cho, et al.
Published: (2017-10-01) -
Lumican is a potential predictor on the efficacy of concurrent chemoradiotherapy in cervical squamous cell carcinoma
by: Ge Hu, et al.
Published: (2023-07-01)